Future work on this project will directly target Gli2 in syngeneic murine liposarcoma models to determine if Gli2-mediated Hedgehog signaling contributes to intrinsic tumor dedifferentiation and stemness or immune exclusion. This evidence concerns the gene GLI2 and liposarcoma.